Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000619204 | SCV000739792 | uncertain significance | Cardiovascular phenotype | 2018-05-15 | criteria provided, single submitter | clinical testing | The p.G1994A variant (also known as c.5981G>C), located in coding exon 48 of the FBN1 gene, results from a G to C substitution at nucleotide position 5981. The glycine at codon 1994 is replaced by alanine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002506511 | SCV002817091 | uncertain significance | Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome | 2021-10-16 | criteria provided, single submitter | clinical testing |